LYSOVETA™ investor presentation
24.11.20 - LPC - Investor & analyst conference call with Matts Johansen, CEO | Martin Stenshall, Head of Investor Relations | Andreas Storsve, Director of R&D
CARL CHR. BACHKE
SVP Investor Relations, Aker BioMarine ASA
+47 909 808 48
ANNUAL REPORT 2020
IMPROVING HUMAN AND PLANETARY HEALTH
Aker BioMarine is a biotech innovator and Antarctic krill-harvesting company, dedicated to improving human and planetary health. Aker BioMarine’s fully transparent value chain stretches from sustainable krill harvesting in pristine Antarctic waters through its Montevideo logistics hub, Houston production plant, and to customers around the world.